|
|
||||||||
1 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore 21205; and 2 Department of Biological Chemistry, University of Maryland, Baltimore, Maryland 21201
841, 2002. First
published November 8, 2001; 10.1152/ajpheart. 00880.2001.
The
beneficial effect of hemodilution on cerebral blood flow (CBF) during
focal cerebral ischemia is mitigated by reduced arterial oxygen
content (CaO2). In anesthetized cats subjected to
permanent middle cerebral artery occlusion, the time course of regional
CBF was evaluated after isovolemic exchange transfusion with either
albumin or a tetrameric hemoglobin-based oxygen carrier. The
transfusion started 30 min after arterial occlusion. We tested the
hypothesis that bulk oxygen transport (CBF × CaO2) to ischemic tissue is increased by
hemoglobin transfusion at a hematocrit of 18% compared with
albumin-transfused cats at a hematocrit of 18% or control cats at a
hematocrit of 30% and equivalent arterial pressure. In the
nonischemic hemisphere, CBF increased selectively after albumin
transfusion, and oxygen transport was similar among groups. In the
ischemic cortex, albumin transfusion increased CBF, but oxygen
transport was not increased above that of the control group. Hemoglobin
transfusion increased both CBF and oxygen transport in the
ischemic cortex above values in the control group, but the
increase was delayed until 4 h of ischemia. Consequently, acute injury volume measured at 6 h of ischemia was not
significantly attenuated. In contrast to the cortex, CBF in the
ischemic caudate nucleus was not substantially increased by
either albumin or hemoglobin transfusion. Therefore, in a large animal
model of permanent focal ischemia in which transfusion starts
30 min after ischemia, tetrameric cross-linked hemoglobin
transfusion can augment oxygen transport to the ischemic
cortex, but the increase can be delayed and not necessarily provide
protection. Moreover, an end-artery region such as the caudate nucleus
is less likely to benefit from hemodilution.
blood substitute; hemodilution; oxygen transport; stroke
This article has been cited by other articles:
![]() |
G. M. T. Hare, C. D. Mazer, J. S. Hutchison, A. T. McLaren, E. Liu, A. Rassouli, J. Ai, R. E. Shaye, J. A. Lockwood, C. E. Hawkins, et al. Severe hemodilutional anemia increases cerebral tissue injury following acute neurotrauma J Appl Physiol, September 1, 2007; 103(3): 1021 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nemoto, T. Mito, W. S Brinigar, C. Fronticelli, and R. C. Koehler Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse J Appl Physiol, May 1, 2006; 100(5): 1688 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. T. Hare, K. M. Hum, S. Y. Kim, A. Barr, A. J. Baker, and C. D. Mazer Increased Cerebral Tissue Oxygen Tension After Extensive Hemodilution with a Hemoglobin-Based Oxygen Carrier Anesth. Analg., August 1, 2004; 99(2): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. T. Hare, C. D. Mazer, W. Mak, R. M. Gorczynski, K. M. Hum, S. Y. Kim, L. Wyard, A. Barr, R. Qu, and A. J. Baker Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression J Appl Physiol, May 1, 2003; 94(5): 2058 - 2067. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |